Filed before 2025Filed 6 December 2023
Sensorium Therapeutics, Inc. has sold $24.7M so far
Sensorium Therapeutics, Inc., a pharmaceuticals company based in Boston, MA, has sold $24.7M so far in its equity round, according to a filing dated 6 December 2023.
Raises filed before 2025 are not checked for a public announcement.
- Filed
- 6 December 2023
- First filed
- 4 October 2022
- Round
- Equity round (amended filing)
- Amount sold
- $24.7M
- Offering size
- $24.8M
- Investors so far
- 64
- Based in
- Boston, MA
- Website
- sensorium.bio
Investors on the board
Firms come from the venture funds whose filings name a director of this company.
Who is on the board
1 director of this company is named on venture funds' filings. Sign in free with Google to see who, the full filing, and a short list of rounds like this each morning.
Sign in with GoogleHow it compares
Larger than 82% of the 1,396 tracked raises with an amount filed in 2023.
Sensorium Therapeutics, Inc. in public filings
| Filed | Filing | Sold | Raise |
|---|---|---|---|
| 15 Jul 2025 | Amended filing | $26.8M | Another raise |
| 12 Feb 2025 | New filing | $14.5M | Another raise |
| 6 Dec 2023 | Amended filing | $24.7M | This raise |
| 4 Oct 2022 | New filing | $15.5M | This raise |
More with Sante Health Ventures on the board
- Reimagine Care, Inc.$2.42M
- Gradalis, Inc.$12.7M
- Molecular Templates, Inc.$20M
- Clairity, Inc.$6.67M
Other unannounced rounds
- DVx Atomic Co.$18.5M
- Aperio Systems, Inc.$1.6M
- Twin Health, Inc.$59M
- Scoring Factory AI Inc.$500K
- Royal & Pelham, Inc.$5.4M
- SPECTRA Holdings US, Ltd.$2.5M
Seen it announced?
Send the link and the check will look at it.